Course curriculum
-
-
Abdominal aortic aneurysm monitoring - 2Qs (January 2023)
-
Abnormal ECG (September 2019)
-
Abnormal PTT (November 2020)
-
ACE inhibitor and ARB use in diabetes (July 2018)
-
Acute Aortic dissection (January 2019)
-
Acute hypertensive complications - 2Qs (May 2022)
-
Acute ischemic stroke - management - 4Qs (January 2019)
-
Acute limb ischemia - 2Qs (January 2021)
-
Acute management of blood pressure in stroke - 2Qs (July 2020)
-
Acute myocardial infarction - algorithm (September 2020)
-
Amiodarone - 2Qs (May 2021)
-
Amniotic fluid embolism (May 2019)
-
Anemia in children - 3Qs (May 2020)
-
Anemia of chronic disease - 2Qs (March 2021)
-
Anemia in the elderly - 2Qs (March 2019)
-
Ankle brachial index testing (July 2019)
-
Anticoagulation after venous thromboembolism (May 2023)
-
Anticoagulation and the surgical patient (January 2020)
-
Antiplatelet therapy and acute coronary syndrome (July 2021)
-
Aortic aneurysm - 2Qs (November 2022)
-
Aortic dissection - 2Qs (May 2020)
-
Aortic stenosis - 3Qs (May 2023)
-
Apical ballooning syndrome (January 2021)
-
Aspirin and primary prevention of cardiovascular disease - 2Qs (September 2019)
-
Aspirin therapy (September 2023)
-
Aspirin therapy in diabetics (September 2021)
-
Atrial fibrillation and anticoagulation - 2Qs (March 2022)
-
Atrial fibrillation - rate versus rhythm control (November 2020)
-
Atrial septal defects (November 2019)
-
Autoimmune hemolytic anemia (September 2018)
-
Behcet's syndrome - 3Qs (May 2020)
-
Bempedoic acid (May 2023)
-
Beta-blockers in heart failure (May 2022)
-
Beta-blockers - Perioperative (May 2020)
-
Beta-blockers and cardiovascular disease - 2Qs (November 2018)
-
Bicuspid aortic valve - 2Q (July 2021) UPDATED
-
Bicuspid aortic valve - 3Qs (July 2019)
-
Blood transfusion threshold (July 2018)
-
Blunt cardiac injury (May 2019)
-
B-type natriuretic peptide (BNP) (March 2023)
-
Bundle branch block (July 2021)
-
Carbon Monoxide Exposure (November 2020)
-
Cardiac autonomic neuropathy - 2Qs (July 2021)
-
Cardiac rehabilitation - 2Qs (March 2023)
-
Cardiac resynchronization therapy (November 2022)
-
Cardiac stenting - 3Qs (November 2020)
-
Cardiogenic shock - 2Qs (July 2018)
-
Cardiomyopathy - Hypertrophic- 3Qs (January 2020)
-
Cardiomyopathy - overview (March 2021)
-
Cardiomyopathy - peripartum - 2Qs (March 2022)
-
Cardiovascular screening of student athletes - 2Q (March 2021)
-
Carotid artery stenosis - treatment (May 2022)
-
Carotid stenosis (November 2019)
-
Central retinal artery occlusion (July 2019)
-
Central sleep apnea (January 2023)
-
Cervical adenopathy (May 2023)
-
Chronic hypertension and pregnancy - 3Qs (March 2020)
-
Chronic kidney disease - 2Qs (May 2022)
-
Chronic lymphocytic leukemia (May 2023)
-
Coffee and health (July 2021)
-
Congenital prolonged QT syndrome - 2Qs (May 2023)
-
Contraception and cardiovascular disease - 2Qs (May 2019)
-
Contraception and stroke risk (May 2023)
-
CoQ10 supplementation (September 2021)
-
Coronary artery calcium scoring - 2Qs (November 2021)
-
Coronary artery calcium screening (January 2020)
-
Coronary artery disease - secondary prevention - 3Q (January 2021)
-
Cyanotic heart disease - 4Qs (March 2020)
-
DASH eating plan (September 2018)
-
Daylight saving time (May 2023)
-
Deep venous thrombosis and long distance travel (November 2019)
-
Depression and cardiovascular disease - 2Qs (January 2022)
-
Dietary salt and cardiovascular disease - 2Qs (May 2019)
-
Digoxin toxicity (May 2022)
-
Digoxin toxicity (November 2018)
-
Dilated cardiomyopathy - 3Qs (March 2023)
-
Dilated cardiomyopathy - 2Qs (March 2021)
-
Drowning (September 2019)
-
Drug-induced thrombocytopenia - 2Qs (January 2023)
-
Drug interactions and bleeding risk - Choosing Wisely (March 2023)
-
DVT Diagnosis - 2Qs (November 2020)
-
ECG abnormalities and psychotropic medications - 2Qs (January 2022)
-
Endocarditis - 5Qs (November 2020)
-
Endocarditis prophylaxis (January 2023)
-
Eosinophilia - 2Qs (May 2020)
-
Erectile dysfunction and cardiovascular disease (July 2021)
-
Erectile dysfunction - lifestyle modification (January 2023)
-
Erectile dysfunction and lifestyle modification - 2Qs (September 2019)
-
Evaluation of the patient with bleeding - 4Qs (January 2019)
-
Fiber - 2Qs (November 2022)
-
Fibrates - 2Qs (January 2022)
-
Headache in pregnancy - 3Qs (July 2019)
-
Heart failure - 2Qs (July 2021)
-
Heart failure - Acute - 2Qs (July 2020)
-
Heart failure - medical treatment - 5Qs (July 2020)
-
Heart failure with preserved ejection fraction - 3Qs (May 2021)
-
Heparin-induced thrombocytopenia (March 2021)
-
Hereditary spherocytosis - 3Qs (May 2022)
-
HIV and cardiovascular disease -2Qs (January 2020)
-
HIV and long-term comorbidities (July 2022)
-
Hodgkin lymphoma - Classic - 5Qs (May 2020)
-
Hydroxyurea and sickle cell disease - 2Qs (January 2019)
-
Hyperlipidemia - nonstatin treatment - 2Qs (November 2022) - UPDATED
-
Hyperlipidemia - nonstatin treatment (September 2020)
-
Hypertension in adolescents - 2Qs (September 2020)
-
Hypertension - Gestational - 3Qs (March 2020)
-
Hypertension in the elderly (July 2021)
-
Hypertensive emergency - 2Qs (January 2021)
-
Hypertriglyceridemia - 2Qs (July 2021) UPDATED
-
Hypertriglyceridemia - 2Qs (November 2018)
-
Immune thrombocytopenia (ITP) (September 2020)
-
Infections and cardiovascular disease -2Qs (January 2021)
-
Infection of cardiac implantable electronic devices - 2Qs (January 2023)
-
Inferior vena cava filter - 2Qs (July 2022)
-
Inferior vena cava filters - 2Qs (May 2021)
-
Intracranial aneurysm (July 2018)
-
Intracranial arterial stenosis (September 2018)
-
Iron overload disorders - 3Qs (May 2021)
-
Ischemic stroke in young adults - 2Qs (March 2021)
-
Ischemic stroke - management - 4Qs (November 2018)
-
Ivabradine and heart failure (July 2020)
-
JNC-8 recommendations - 3Qs (July 2021)
-
Kawasaki disease (May 2019)
-
Lipid guidelines - 3Qs (May 2019)
-
Macrocytic anemia - 5Qs (July 2019)
-
Masked and white coat hypertension - 2Qs (July 2022)
-
Mechanical heart valve and pregnancy - 2Qs (May 2019)
-
Medications causing heart failure - 5Qs (November 2022)
-
Mitral valve prolapse - 2Qs (May 2019)
-
Myocardial infarction with nonobstructive coronary disease - 3Qs (September 2021)
-
Myocarditis - 2Qs (March 2021)
-
Niacin - 2Qs (November 2022)
-
Non-lipid statin use - 2Qs (November 2021)
-
NSAIDs and cardiovascular disease - 2Qs (January 2019)
-
Oral contraceptives and risk of venous thromboembolism (March 2020)
-
Patent foramen ovale - 2Qs (March 2020)
-
Pericarditis - Acute - 2Qs (September 2018)
-
Peripartum cardiomyopathy (March 2021)
-
Peripheral artery disease - 2Qs (May 2022)
-
Peripheral artery disease - 3Qs (July 2020)
-
Polycythemia vera - 3Qs (January 2021)
-
Postpartum eclampsia (January 2019)
-
Postprandial hypotension - 2Qs (May 2020)
-
Post-prandial hypotension - 2Qs (July 2021)
-
Post-thrombotic syndrome - 2Qs (November 2021)
-
Postural orthostatic tachycardia - 2Qs (July 2020)
-
Postural orthostatic tachycardia syndrome (September 2019)
-
Preeclampsia early onset - 2Qs (July 2021)
-
Preoperative cardiac assessment - 3Qs (March 2023)
-
Preparticipation physical exam - 2Qs (May 2022)
-
Preventing IV catheter infection - 2Qs (January 2022)
-
Prevention of recurrent stroke - 2Qs (November 2020)
-
Pulmonary embolism - incidental (January 2019)
-
Pulmonary embolism - subsegmental - 2Qs (March 2019)
-
Pulmonary hypertension - 3Qs (March 2022)
-
Raynaud's phenomenon - 2Qs (May 2022)
-
Renal artery stenosis - 2Qs (January 2023)
-
Reproductive history and CVD risk - 2Qs (March 2021)
-
Resistant hypertension - 2Qs (September 2018)
-
Resting tachycardia (January 2022)
-
Resting sinus tachycardia - 2Qs (September 2021)
-
Retinopathy of prematurity - 3Qs (January 2023)
-
Rheumatic fever - acute - 3Qs (March 2022)
-
Screening for hypertension (January 2023)
-
Sickle cell disease - overview - 4Qs (March 2023)
-
Sports and co-morbid conditions - 3Qs (January 2020)
-
Statins and primary prevention - 2Qs (July 2019)
-
Statin side effects - 3Qs (January 2021)
-
Stroke risk after transient ischemic attack (March 2023)
-
Superficial thrombophlebitis (January 2020)
-
Syncope in adults - 4Qs (September 2020)
-
Systolic Blood Pressure Intervention Trial (SPRINT) (November 2018)
-
Systolic hypertension - Isolated - 2Qs (May 2020)
-
Takotsubo cardiomyopathy - 3Qs (January 2020)
-
Temporal arteritis (March 2019)
-
Thoracic aortic dissection - Acute - (September 2022)
-
Thrombocytosis (November 2018)
-
Thrombolysis after stroke -2Qs (March 2020)
-
Thrombotic thrombocytopenic purpura - 2Qs (September 2019)
-
Transfusion reactions - 3Qs (March 2019)
-
Transient ischemic attack (TIA) - 3Qs (January 2021)
-
Understanding lipid recommendations - 2Qs (September 2018)
-
Unprovoked venous thrombosis - 4Qs (November 2019)
-
Varicose veins - 2Qs (September 2022)
-
Venous thromboembolism and malignancy - 2Qs (January 2019)
-
Ventriculoseptal defect - 2Qs (July 2021)
-
About this course
- Free
- 186 lessons
- 0 hours of video content